488 related articles for article (PubMed ID: 16086034)
41. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
[TBL] [Abstract][Full Text] [Related]
42. Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway.
Pang X; Liu J; Li Y; Zhao J; Zhang X
PLoS One; 2015; 10(7):e0131295. PubMed ID: 26131983
[TBL] [Abstract][Full Text] [Related]
43. Platelet-derived growth factor-BB-induced hypertrophy of peritubular smooth muscle cells is mediated by activation of p38 MAP-kinase and of Rho-kinase.
Romano F; Chiarenza C; Palombi F; Filippini A; Padula F; Ziparo E; De Cesaris P
J Cell Physiol; 2006 Apr; 207(1):123-31. PubMed ID: 16270352
[TBL] [Abstract][Full Text] [Related]
44. Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox.
Zou T; Yang W; Hou Z; Yang J
Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):908-15. PubMed ID: 21068125
[TBL] [Abstract][Full Text] [Related]
45. Induction of interleukin-8 secretion and activation of ERK1/2, p38 MAPK signaling pathways by thrombin in dermal fibroblasts.
Wang L; Luo J; Fu Y; He S
Int J Biochem Cell Biol; 2006; 38(9):1571-83. PubMed ID: 16697690
[TBL] [Abstract][Full Text] [Related]
46. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor.
Selvaraj SK; Giri RK; Perelman N; Johnson C; Malik P; Kalra VK
Blood; 2003 Aug; 102(4):1515-24. PubMed ID: 12689930
[TBL] [Abstract][Full Text] [Related]
47. PI-3K/AKT signal pathway modulates vascular smooth muscle cells migration under cyclic mechanical strain.
Zhang BC; Zhou ZW; Li XK; Xu YW
Vasa; 2011 Mar; 40(2):109-16. PubMed ID: 21500175
[TBL] [Abstract][Full Text] [Related]
48. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
49. Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration.
Chen SC; Wang BW; Wang DL; Shyu KG
Biochem Biophys Res Commun; 2008 Oct; 374(4):662-7. PubMed ID: 18664364
[TBL] [Abstract][Full Text] [Related]
50. cAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration.
Ono H; Ichiki T; Fukuyama K; Iino N; Masuda S; Egashira K; Takeshita A
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1634-9. PubMed ID: 15242860
[TBL] [Abstract][Full Text] [Related]
51. Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling.
Doronzo G; Russo I; Mattiello L; Riganti C; Anfossi G; Trovati M
Diabetologia; 2006 May; 49(5):1049-63. PubMed ID: 16506055
[TBL] [Abstract][Full Text] [Related]
52. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.
Tanimoto T; Lungu AO; Berk BC
Circ Res; 2004 Apr; 94(8):1050-8. PubMed ID: 15044318
[TBL] [Abstract][Full Text] [Related]
53. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection.
Lee TS; Chang CC; Zhu Y; Shyy JY
Circulation; 2004 Sep; 110(10):1296-302. PubMed ID: 15337692
[TBL] [Abstract][Full Text] [Related]
54. [Effects of glycosides components and combinations of Buyang Huanwu decoction on vascular smooth muscle cells proliferation and related signaling pathway].
Cao L; Deng CQ
Zhongguo Zhong Yao Za Zhi; 2016 May; 41(10):1889-1897. PubMed ID: 28895339
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.
Dong X; Yu LG; Sun R; Cheng YN; Cao H; Yang KM; Dong YN; Wu Y; Guo XL
J Cell Biochem; 2013 Jan; 114(1):174-82. PubMed ID: 22887358
[TBL] [Abstract][Full Text] [Related]
56. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.
Doronzo G; Viretto M; Russo I; Mattiello L; Di Martino L; Cavalot F; Anfossi G; Trovati M
Atherosclerosis; 2011 May; 216(1):44-53. PubMed ID: 21316056
[TBL] [Abstract][Full Text] [Related]
57. Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability.
Yu SH; Yu JM; Yoo HJ; Lee SJ; Kang DH; Cho YJ; Kim DM
Yonsei Med J; 2016 Mar; 57(2):373-81. PubMed ID: 26847289
[TBL] [Abstract][Full Text] [Related]
58. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
Nagareddy PR; MacLeod KM; McNeill JH
Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
[TBL] [Abstract][Full Text] [Related]
59. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
60. Crocin prevents platelet‑derived growth factor BB‑induced vascular smooth muscle cells proliferation and phenotypic switch.
Tong L; Qi G
Mol Med Rep; 2018 Jun; 17(6):7595-7602. PubMed ID: 29620234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
